Our personalized cell therapy is highly accessible, patient-friendly and physician-friendly.
Life-Changing Treatments for Patients
BioGenCell is dedicated to changing the lives of patients suffering from degenerative microvascular diseases, stopping disease progression, reversing disability, reducing pain, and enhancing functionality.
Vascular diseases are the primary cause of mortality worldwide, representing 25% of fatalities. BioGenCell’s groundbreaking cell-therapy treatments aim to provide more accessible, reliable and cost-effective therapeutic options, with the hope of significantly impacting these tragic figures.
Join a Journey that Brings New Hope to No-Option Chronic Limb-Threatening Ischemia (CLTI) Patients with BioGenCell’s Phase 2 Clinical Trial for BGC101.
Our team of experts brings to the table decades of experience and an unbridled passion for biomedicine. We have set our sights on improving patients lives by making cell therapy simple and accessible, patients friendly – and physician friendly.